The first stage of the Zero Childhood Cancer program began in 2016 with a pilot study for children with high-risk cancer being treated in NSW.
During this pilot, the platform required to create a personalised medicine pipeline was established and tested. This involved multiple steps, including developing a process for cancer samples to be sent, from all over Australia, to a centralised tumour bank, along with the establishment of the best possible methods for molecular profiling, drug screening and efficacy testing.
In 2017, following the successful completion of the pilot, a national clinical trial was launched. By the end of October 2018, 127 children with high-risk cancers from all over Australia had been enrolled on the state-of-the-art trial.
The trial is free to all children who meet enrolment criteria and is being sponsored by the Australian and New Zealand Haematology/Oncology group (ANZCHOG).

Where to from here?
The Zero Childhood Cancer clinical trial will remain open until 2020 and will be recruiting new children with aggressive cancer each year until then.
Due to the complex nature of childhood cancer, the extraordinary outcome that Ellie experienced will not be possible for every child. However, the more that is learned, the more remarkable success stories like Ellie’s are likely in the future.
Through the trial, Zero Childhood Cancer is generating a wealth of new research data, including valuable molecular and genetic information about childhood cancers.
This data is adding enormously to our knowledge and understanding of childhood cancer and will be shared nationally and internationally to contribute to future research discoveries. In this way, Zero Childhood Cancer is not only benefiting children today, but will continue to benefit all children with cancer in the future. 
Donate to research and help find more effective treatments for kids with cancer.

The Kids' Cancer Project is an ACNC Registered Charity 
ABN 13 061 138 181 | CFN 10581